The standard treatment procedure for lung adenocarcinoma includes DNA-based gene expression profiling, whiles protein expression analysis (e.g., PDL1) is gaining prominence, which is mostly owing to immune therapy (Wang L. et al., 2020). The gene discussed is CD274; the disease is lung adenocarcinoma.